Barclays
STJ

Barclays’s St Jude Medical STJ Stock Holding History

Barclays’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,100
Closed -$86K – 6983
2016
Q2 		$86K Sell
1,100
-26,800
-96% -$1.91M ﹤0.01% 4514
2016
Q1 		$1.53M Buy
27,900
+3,000
+12% +$163K ﹤0.01% 2159
2015
Q4 		$1.52M Sell
24,900
-153,700
-86% -$9.69M ﹤0.01% 2250
2015
Q3 		$11.3M Buy
178,600
+81,000
+83% +$5.78M 0.01% 866
2015
Q2 		$7.13M Sell
97,600
-13,100
-12% -$946K 0.01% 1243
2015
Q1 		$7.2M Buy
110,700
+91,400
+474% +$6.08M 0.01% 1294
2014
Q4 		$1.25M Sell
19,300
-12,700
-40% -$818K ﹤0.01% 2979
2014
Q3 		$1.92M Buy
32,000
+12,300
+62% +$804K ﹤0.01% 2701
2014
Q2 		$1.36M Buy
19,700
+15,200
+338% +$985K ﹤0.01% 3027
2014
Q1 		$293K Sell
4,500
-70,800
-94% -$4.61M ﹤0.01% 4426
2013
Q4 		$4.59M Sell
75,300
-229,500
-75% -$13.3M ﹤0.01% 1901
2013
Q3 		$16.2M Sell
304,800
-188,100
-38% -$9.69M 0.02% 806
2013
Q2 		$22.5M Buy
+492,900
New +$21.4M 0.03% 594

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Barclays's STJ Position: Q1 2017 in Review

Barclays sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,926,524 shares — an estimated $235M sold.

Barclays first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $301M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Barclays reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Barclays sold 2,926,524 St Jude Medical shares in Q1 2017, an estimated $235M.
  • Barclays first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Barclays's St Jude Medical position peaked at $301M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.